Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
$0.66
$0.74
$0.55
$4.56
$16.15MN/AN/A574,675 shs
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
$0.01
-17.6%
$0.17
$0.01
$1.90
$411K0.3236.15 million shs409.72 million shs
KALA BIO, Inc. stock logo
KALA
KALA BIO
$3.67
-4.4%
$3.90
$2.92
$11.20
$23.68M-1.9193,996 shs21,174 shs
Zhongchao Inc. stock logo
ZCMD
Zhongchao
$1.16
+3.9%
$1.21
$0.95
$2.97
$29.25M-0.04322,976 shs940 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
0.00%0.00%0.00%0.00%0.00%
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
0.00%+29.31%-97.22%-98.32%-98.91%
KALA BIO, Inc. stock logo
KALA
KALA BIO
0.00%-9.16%-1.34%-47.04%-41.56%
Zhongchao Inc. stock logo
ZCMD
Zhongchao
0.00%+0.87%-0.43%-11.45%-5.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
0.5907 of 5 stars
0.03.00.00.02.90.00.6
KALA BIO, Inc. stock logo
KALA
KALA BIO
3.9016 of 5 stars
3.53.00.04.42.70.00.6
Zhongchao Inc. stock logo
ZCMD
Zhongchao
1.096 of 5 stars
0.03.00.00.03.31.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
0.00
N/AN/AN/A
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
0.00
N/AN/AN/A
KALA BIO, Inc. stock logo
KALA
KALA BIO
3.00
Buy$13.50267.85% Upside
Zhongchao Inc. stock logo
ZCMD
Zhongchao
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ZCMD, KALA, ACER, and HCTI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2025
KALA BIO, Inc. stock logo
KALA
KALA BIO
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
4/4/2025
KALA BIO, Inc. stock logo
KALA
KALA BIO
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
(Data available from 6/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
N/AN/AN/AN/AN/AN/A
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
$11.29M0.03N/AN/A$0.12 per share0.06
KALA BIO, Inc. stock logo
KALA
KALA BIO
$3.89M6.09N/AN/A$2.79 per share1.32
Zhongchao Inc. stock logo
ZCMD
Zhongchao
$15.86M1.84N/AN/A$10.24 per share0.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
-$26.24MN/A0.00N/AN/AN/AN/AN/A
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
-$12.34M-$2.18N/AN/A-60.08%-773.20%-143.68%N/A
KALA BIO, Inc. stock logo
KALA
KALA BIO
-$42.20M-$8.24N/AN/AN/AN/A-448.61%-69.37%8/5/2025 (Estimated)
Zhongchao Inc. stock logo
ZCMD
Zhongchao
-$11.34MN/A0.00N/AN/AN/AN/AN/A

Latest ZCMD, KALA, ACER, and HCTI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2025Q1 2025
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
N/A-$0.17N/A-$0.17N/A$3.70 million
3/28/2025Q4 2024
KALA BIO, Inc. stock logo
KALA
KALA BIO
-$2.28-$1.74+$0.54-$1.74N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
N/AN/AN/AN/AN/A
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
N/AN/AN/AN/AN/A
KALA BIO, Inc. stock logo
KALA
KALA BIO
N/AN/AN/AN/AN/A
Zhongchao Inc. stock logo
ZCMD
Zhongchao
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
N/AN/AN/A
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
N/A
0.29
0.29
KALA BIO, Inc. stock logo
KALA
KALA BIO
3.18
2.15
2.15
Zhongchao Inc. stock logo
ZCMD
Zhongchao
N/A
6.05
5.94

Institutional Ownership

CompanyInstitutional Ownership
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
N/A
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
0.33%
KALA BIO, Inc. stock logo
KALA
KALA BIO
24.61%
Zhongchao Inc. stock logo
ZCMD
Zhongchao
1.67%

Insider Ownership

CompanyInsider Ownership
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
20.20%
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
1.61%
KALA BIO, Inc. stock logo
KALA
KALA BIO
8.32%
Zhongchao Inc. stock logo
ZCMD
Zhongchao
28.63%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acer Therapeutics Inc. stock logo
ACER
Acer Therapeutics
3024.46 million19.52 millionNot Optionable
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
8045.21 million6.24 millionNot Optionable
KALA BIO, Inc. stock logo
KALA
KALA BIO
306.45 million5.58 millionNot Optionable
Zhongchao Inc. stock logo
ZCMD
Zhongchao
14025.22 million18.00 millionNot Optionable

Recent News About These Companies

Zhongchao Inc. Reports Mixed Financial Results for 2024
What's Going On With Zhongchao Stock Today?
Why Is Zhongchao (ZCMD) Stock Up 52% Today?
Zhongchao Inc. (ZCMD)
Why Is Zhongchao (ZCMD) Stock Up 103% Today?
ZHONGCHAO Inc Ordinary Shares - Class A
Why Is Zhongchao (ZCMD) Stock Up 40% Today?
Why Is Zhongchao (ZCMD) Stock Up 15% Today?
Zhongchao Inc. Announces 1-for-10 Share Consolidation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Acer Therapeutics stock logo

Acer Therapeutics NASDAQ:ACER

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. The company's pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-801 for the treatment of induced Vasomotor Symptoms, post-traumatic stress disorder, and prostate cancer; and OLPRUVA, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease. It has a license agreement with Sanofi to acquire worldwide rights to Osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist; an option agreement with Relief for the development, regulatory approval, and commercialization of OLPRUVA; and an agreement with Emory University to acquire the worldwide intellectual property rights to a family of patents and patent applications related to the use of neurokinin receptor antagonists in managing conditioned fear and treating anxiety disorders, including post-traumatic stress disorder. The company was incorporated in 1991 and is headquartered in Newton, Massachusetts.

Healthcare Triangle stock logo

Healthcare Triangle NASDAQ:HCTI

$0.0075 0.00 (-17.58%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$0.01 0.00 (-4.00%)
As of 05/30/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; and DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, the company offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery on public cloud. It primarily serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. The company was incorporated in 2019 and is based in Pleasanton, California. Healthcare Triangle, Inc. is a subsidiary of SecureKloud Technologies, Inc.

KALA BIO stock logo

KALA BIO NASDAQ:KALA

$3.67 -0.17 (-4.43%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$3.74 +0.07 (+1.91%)
As of 05/30/2025 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KALA BIO, Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies for rare and severe eye diseases in the United States. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Zhongchao stock logo

Zhongchao NASDAQ:ZCMD

$1.16 +0.04 (+3.92%)
Closing price 05/30/2025 03:57 PM Eastern
Extended Trading
$1.16 0.00 (0.00%)
As of 05/30/2025 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.